Respiratory symptoms and lung function in 30-year-old individuals with alpha-1-antitrypsin deficiency

Respiratory Medicine

Volumn 101, Issue 9, 2007, Pages 1971-1976

  Bernspång, Elisabeth ^a   Sveger, Tomas ^a   Piitulainen, Eeva ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Alpha1 antitrypsin deficiency; COPD; Lung function; Neonatal screening; Respiratory symptom

Indexed keywords

ALPHA 1 ANTITRYPSIN;

ADULT; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; NEWBORN SCREENING; PREDICTION; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SMOKING HABIT; SPIROMETRY; SYMPTOMATOLOGY;

ADULT; ALPHA 1-ANTITRYPSIN DEFICIENCY; COHORT STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INFANT, NEWBORN; MALE; NEONATAL SCREENING; PATIENT DROPOUTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; SPIROMETRY; VITAL CAPACITY;

EID: 34547489085     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2007.04.003     Document Type: Article

References (24)

1. Seersholm N., and Kok-Jensen A. Clinical features and prognosis of life time non-smokers with severe alpha 1-antitrypsin deficiency. Thorax 53 4 (1998) 265-268
2. Eriksson S., Carlson J., and Velez R. Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency. N Engl J Med 314 12 (1986) 736-739
3. Sveger T. Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants. N Engl J Med 294 24 (1976) 1316-1321
4. Sveger T., and Eriksson S. The liver in adolescents with alpha 1-antitrypsin deficiency. Hepatology 22 2 (1995) 514-517
5. Seersholm N., and Kok-Jensen A. Intermediate alpha 1-antitrypsin deficiency PiSZ: a risk factor for pulmonary emphysema?. Respir Med 92 2 (1998) 241-245
6. Piitulainen E., and Sveger T. Effect of environmental and clinical factors on lung function and respiratory symptoms in adolescents with alpha1-antitrypsin deficiency. Acta Paediatr 87 11 (1998) 1120-1124
7. Sveger T., Piitulainen E., and Arborelius Jr. M. Clinical features and lung function in 18-year-old adolescents with alpha 1-antitrypsin deficiency. Acta Paediatr 84 7 (1995) 815-816
8. Piitulainen E., Carlson J., Ohlsson K., and Sveger T. Alpha1-antitrypsin deficiency in 26-year-old subjects: lung, liver, and protease/protease inhibitor studies. Chest 128 4 (2005) 2076-2081
9. Ferris B.G. Epidemiology Standardization Project (American Thoracic Society). Am Rev Respir Dis 118 6 Pt 2 (1978) 1-120
10. Piitulainen E., and Sveger T. Respiratory symptoms and lung function in young adults with severe alpha(1)-antitrypsin deficiency (PiZZ). Thorax 57 8 (2002) 705-708
11. Siafakas N.M., Vermeire P., Pride N.B., Paoletti P., Gibson J., Howard P., et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J 8 8 (1995) 1398-1420
12. Berglund E., Birath G., Bjure J., Grimby G., Kjellmer I., Sandqvist L., et al. Spirometric studies in normal subjects. I. Forced expirograms in subjects between 7 and 70 years of age. Acta Med Scand 173 (1963) 185-192
13. American Thoracic Society/European Respiratory Society Statement: Standards for the Diagnosis and Management of Individuals with Alpha-1 Antitrypsin Deficiency. Am J Respir Crit Care Med 168 7 (2003) 818-900
14. Larsson C. Natural history and life expectancy in severe alpha1-antitrypsin deficiency, Pi Z. Acta Med Scand 204 5 (1978) 345-351
15. Dahl M., Hersh C.P., Ly N.P., Berkey C.S., Silverman E.K., and Nordestgaard B.G. The protease inhibitor PI*S allele and COPD: a meta-analysis. Eur Respir J 26 1 (2005) 67-76
16. Sunyer J., Basagana X., Roca J., Urrutia I., Jaen A., Anto J.M., et al. Relations between respiratory symptoms and spirometric values in young adults: the European community respiratory health study. Respir Med 98 10 (2004) 1025-1033
17. Fletcher C., and Peto R. The natural history of chronic airflow obstruction. Br Med J 1 6077 (1977) 1645-1648
18. 1 among patients with severe hereditary alpha 1-antitrypsin deficiency type PiZ. Am J Respir Crit Care Med 152 6 Pt 1 (1995) 1922-1925
19. Piitulainen E., Tornling G., and Eriksson S. Effect of age and occupational exposure to airway irritants on lung function in non-smoking individuals with alpha 1-antitrypsin deficiency (PiZZ). Thorax 52 3 (1997) 244-248
20. Piitulainen E., and Eriksson S. Decline in FEV1 related to smoking status in individuals with severe alpha1-antitrypsin deficiency (PiZZ). Eur Respir J 13 2 (1999) 247-251
21. Burney P.G., Luczynska C., Chinn S., and Jarvis D. The European community respiratory health survey. Eur Respir J 7 5 (1994) 954-960
22. Bostrom G. Chapter 9: habits of life and health. Scand J Public Health Suppl 67 (2006) 199-228
23. Montnemery P., Adelroth E., Heuman K., Johannisson A., Johansson S.A., Lindholm L.H., et al. Prevalence of obstructive lung diseases and respiratory symptoms in southern Sweden. Respir Med 92 12 (1998) 1337-1345
24. Lindstrom M., Kotaniemi J., Jonsson E., and Lundback B. Smoking, respiratory symptoms, and diseases: a comparative study between northern Sweden and northern Finland: report from the FinEsS study. Chest 119 3 (2001) 852-861